Marshall Wace, LLP Biodesix Inc Transaction History
Marshall Wace, LLP
- $78.4 Billion
- Q4 2024
A detailed history of Marshall Wace, LLP transactions in Biodesix Inc stock. As of the latest transaction made, Marshall Wace, LLP holds 15,058 shares of BDSX stock, worth $13,702. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,058Holding current value
$13,702% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BDSX
# of Institutions
64Shares Held
56.3MCall Options Held
342KPut Options Held
10.1K-
Telemark Asset Management, LLC Boston, MA8.28MShares$7.54 Million1.33% of portfolio
-
Aigh Capital Management LLC Baltimore, MD6.18MShares$5.62 Million3.75% of portfolio
-
Bryn Mawr Trust CO Bryn Mawr, PA6.1MShares$5.55 Million0.17% of portfolio
-
Birchview Capital, LP Burlington, VT5.58MShares$5.08 Million7.15% of portfolio
-
Silverarc Capital Management, LLC4.33MShares$3.94 Million1.56% of portfolio
About BIODESIX INC
- Ticker BDSX
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 39,982,000
- Market Cap $36.4M
- Description
- Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pat...